Will take Covid vaccine if PM Modi takes first shot: RJD’s Tej Pratap Yadav

By: |
January 8, 2021 12:26 PM

India has given approval to three vaccines — Covishield developed by AstraZeneca in partnership with India-based Serum Institute, Covaxin by Bharat Biotech and Virus-2019-nCov-Vaccine by Cadila Healthcare.

Rashtriya Janata Dal leader Tej Pratap Yadav. (PTI)

Rashtriya Janata Dal leader Tej Pratap Yadav on Friday joined the league of those apprehensive about the safety of Covid-19 vaccines expected to be rolled out by the end of this month. On a question whether he will take the vaccine, the RJD leader said that if Prime Minister Narendra Modi takes the first shot, he will take it as well. India has given approval to three vaccines — Covishield developed by AstraZeneca in partnership with India-based Serum Institute, Covaxin by Bharat Biotech and Virus-2019-nCov-Vaccine by Cadila Healthcare.

However, approval to Bharat Biotech had triggered a massive controversy as the data on third phase trial efficacy was still awaited. The Opposition parties and a section of experts questioned the government, and accused it of risking people’s lives just to show the world that it has a vaccine fully developed in India by an Indian company.

Former UP chief minister Akhilesh Yadav was the first to question the safety of the vaccine. He also announced that he will not take the vaccine developed by “BJP government”, prompting sharp reactions from the saffron party leaders.

On Tuesday, senior Congress leader Manish Tewari targeted the Centre saying it has politically misused the Covid-19 pandemic in its entirety. The controversy over the vaccine, he said, was its latest manifestation. “Who is going to get himself vaccinated with a vaccine (Covaxin by Bharat Biotech) that has question marks on its reliability,” the former minister said.

Tewari further said that the central government had done a great disservice to that company which must have invested crores of rupees in research and development. “In their quest to prove their ‘Atmanirbhar Bharat’ they have licensed a vaccine (Covaxin) whose phase-III trials are not complete,” Tewari said in an apparent reference to Bharat Biotech.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1Supreme Court says Centre’s oxygen policy needs a relook
2Covid-19: Failure of PM, zero strategy of Centre pushing India towards complete lockdown, says Rahul Gandhi
3Oxygen Crisis: Now Centre moves Supreme Court against Karnataka High Court order over O2 supply